NSE: SAGILITY | BSE: 544282

Mid-range Performer

Download real time

40.38 -1.06 (-2.56%)

30.25% Fall from 52W High

28.2M NSE+BSE Volume

NSE 08 Jul, 2026 3:31 PM (IST)

18,903.2

Market Cap

Market Leader

Beta 1Year

Average volatility

Sagility Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SAGILITY, BSE:544282 Sagility Ltd.

Search Inside the pdf :

Sagility Ltd.

27 Mar 2026

40.38

-2.56%

SAGILITY LIMITED

Buy: Sagility Ltd.

Target

Geojit BNP Paribas

Sagility Ltd. is a healthcare-focused, technology-enabled solutions provider primarily serving U.S. health insurers (payers), along with hospitals, physicians, and medical device companies (providers). Headquartered in Bengaluru, the company operates 33 delivery centers across India, the U.S., and other global markets. In Q3FY26, ~90% of its revenue...

Sagility Ltd. is trading above its 30 day SMA of 40.3

Sagility Ltd.

27 Mar 2026

40.38

-2.56%

Sagility (SAGILITY IN) Analyst Meet Update Navigating policy & AI disruption with domain solutions Not Rated

Not Rated: Sagility Ltd.

Prabhudas Lilladhar

Create domain specific agentic AI solutions to expand TAM Sustain revenue momentum while maintaining margins We attended Sagility's Investor Day, where management outlined how US healthcare policy changes and AI adoption are reshaping its business, and how the company is turning these headwinds into growth opportunities. Policy-driven margin pressures on payer clients are accelerating the shift toward cost-saving outsourcing, where Sagility's human in the loop agentic solutions, built on two decades of domain expertise across both payers and providers, can reduce client costs and effort by ~30%...

Sagility Ltd.'s price crossed below 50Day SMA today

Sagility Ltd.

27 Mar 2026

40.38

-2.56%

Analyst meet update: AI - a growth accelerator

Buy: Sagility Ltd.

Target

ICICI Securities Limited

Sagility hosted its first analyst meet (on 25th Mar’26). It highlighted that AI continues to be a key growth driver, woven into most of its solutions and platforms.

Number of FII/FPI investors increased from 199 to 223 in Mar 2026 qtr.

Sagility Ltd.

26 Mar 2026

40.38

-2.56%

Structural complexities and inefficiencies in the US healthcare system remain a key tailwind

Buy: Sagility Ltd.

Target

Motilal Oswal

Growth strategies are clearly anchored around: cost transformation driven by demand from US payers; capability-led differentiation, including AI.

Sagility Ltd. is trading below its 50 day SMA of 41.0

Sagility Ltd.

28 Jan 2026

40.38

-2.56%

A stronger FY26 exit in sight; raises revenue growth guidance

Buy: Sagility Ltd.

Motilal Oswal

Sagility’s 3QFY26 revenue rose 29.1% YoY in Constant Currency (CC), higher than our estimate of 21% YoY CC. EBIT margin stood at 19.7%, and adj. PAT came in at INR3.2b (up 7.3% QoQ and 23.0% YoY), well above our estimate of INR2.8b.

Sagility Ltd.'s price crossed below 50Day SMA today

Sagility Ltd.

10 Sep 2025

40.38

-2.56%

SAGILITY INDIA LIMITED

Buy: Sagility Ltd.

Geojit BNP Paribas

Sagility India Ltd. is a healthcare-focused, technology-enabled solutions provider, serving primarily U.S. health insurers (Payers) and, to a lesser extent, hospitals, physicians, and medical device companies (Providers). Headquartered in Bengaluru, it operates 33 centres across India, the U.S., and other global markets. In Q1FY26, 88.4% of revenue was derived...

Sagility Ltd. is trading below its 50 day SMA of 41.0

Sagility Ltd.

16 May 2025

40.38

-2.56%

Guidance intact; resiliency on display

Buy: Sagility Ltd.

ICICI Securities Limited

Sagility India reported 5.8% QoQ USD revenue growth (organic growth at 0.7%), slightly ahead of I-Sec estimate in Q4FY25. It met its guidance of delivering mid-teens growth in FY25 with 15% YoY USD print.

Number of FII/FPI investors increased from 199 to 223 in Mar 2026 qtr.

Sagility Ltd.

05 Nov 2024

40.38

-2.56%

IPO Note - Sagility India Limited - 05112024

IPO Note: Sagility Ltd.

HDFC Securities

IPO Note - Sagility India Limited Issue Snapshot: Issue Open: November 05 November 07, 2024 Price Band: Rs. 28 30 (Employee discount of Rs 2 per share) *Issue Size: Up to Rs 2106.60 cr (Offer for sale of 70.21 crore shares) Reservation for: QIB atleast 75% eq sh Non-Institutional upto 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail upto 10% eq sh Face Value: Rs 10 Book value: Rs 16.25 (June 30, 2024) Bid size: - 500 equity shares and in multiples thereof 100% Book built Issue